Orphengesic Forte

Product NDC

61825-999

11-digit product format

618250999

Labeler code

61825

Product ID

61825-999_9bbb5fc9-decc-4cec-e053-2a95a90ac30d

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Orphenadrine Citrate, Aspirin and Caffeine

Dosage form

TABLET

Route

ORAL

Labeler

Galt Pharmaceuticals, LLC

Application

ANDA075141

Marketing category

ANDA

Marketing start

2019-06-17

Marketing end

0000-00-00

Substance

ORPHENADRINE CITRATE; ASPIRIN; CAFFEINE

Active strength

50 mg/1; mg/1; mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]

NDC exclude flag

No

Listing certified through

2021-12-31

Current FDA listing

Historical FDA.report record